Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-26

Clinical Trial Update: Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib [NA]

View source ↗

Summary

Trial update describing a study of wearable-enhanced fitness tracking for metastatic breast cancer patients receiving endocrine therapy in combination with palb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palbociclib (palbociclib)

Snippet

Sponsor: Beneficência Portuguesa de São Paulo | Conditions: Breast Neoplasm Female, Quality of Life | NA | Status: RECRUITING